Melatonin is the natural sleep aid with the most clinical evidence behind it, though the results are more modest than most people expect. A major meta-analysis published in PLOS One found that melatonin reduces the time it takes to fall asleep by about seven minutes and increases total sleep time by roughly eight minutes compared to placebo. Those numbers are real, statistically significant, and honestly a bit underwhelming if you were hoping for a miracle. But for people caring for a loved one with dementia, or older adults struggling with fragmented sleep themselves, even small gains in sleep quality can ripple outward into better daytime function, improved mood, and sharper cognition. The fuller picture, however, is more interesting than any single supplement.
Magnesium, glycine, and valerian root have all been studied in randomized controlled trials, and each tells a different story about what “works” actually means when it comes to sleep. Magnesium shows particular promise for older adults, with one trial finding sleep onset came over 17 minutes sooner. Glycine may not help you sleep longer, but it appears to help you feel more rested. And valerian root, despite being one of the oldest herbal remedies on the planet, still can’t quite prove itself in the lab. This article walks through what the clinical evidence actually says for each of these, who benefits most, and where the science falls short.
Table of Contents
- Which Natural Sleep Aids Actually Have Clinical Evidence, and How Strong Is It?
- Melatonin Under the Microscope: Who It Helps and Who It Does Not
- Magnesium’s Quiet Case for Sleep in Older Adults
- Glycine for Feeling Rested on Too Little Sleep
- Why Valerian Root’s Long History Has Not Translated to Clear Evidence
- Chamomile, CBD, and the Supplements That Fall Short
- Where Sleep Science Is Headed for Aging and Brain Health
- Conclusion
- Frequently Asked Questions
Which Natural Sleep Aids Actually Have Clinical Evidence, and How Strong Is It?
The hierarchy is fairly clear. melatonin sits at the top in terms of volume of research. It has been examined across dozens of randomized controlled trials covering everything from jet lag to neurodevelopmental disorders in children to general adult insomnia. A meta-analysis of melatonin’s effects on sleep quality confirmed its statistically significant, if modest, benefits on sleep latency and total sleep time. But here is the critical nuance: melatonin was not significantly effective for improving sleep onset latency, total sleep time, or sleep efficiency in adults with straightforward, non-comorbid insomnia.
Its strongest evidence is for more specific populations, including people with delayed sleep-wake phase disorder, shift workers, and children with neurodevelopmental conditions. Magnesium comes next, with a smaller but compelling evidence base. A meta-analysis of three randomized controlled trials involving 151 older adults found that magnesium supplementation shortened sleep onset latency by 17.36 minutes compared to placebo, a result that was statistically significant with a P value of 0.0006. That is a larger effect size than melatonin showed in its own meta-analyses, though the magnesium data comes from far fewer and smaller studies. Glycine rounds out the group with only three small human studies, but consistent and intriguing findings. Valerian root has the most conflicting evidence: one large review of 60 studies found modest subjective improvements, while another concluded the evidence did not support clinical efficacy at all.
Melatonin Under the Microscope: Who It Helps and Who It Does Not
The widespread assumption that melatonin is a reliable sleep aid for everyone does not hold up. For adults with general insomnia who have no other complicating health condition, the data is surprisingly weak. The benefits that do show up in large analyses are driven heavily by specific subgroups. If you are dealing with jet lag after a transatlantic flight, melatonin has solid backing. If you are a shift worker trying to sleep during daylight hours, it can help recalibrate your circadian rhythm. But if you are a 65-year-old lying awake at night with no clear circadian disruption, melatonin may not be the answer the supplement aisle promised.
Safety is one area where melatonin genuinely excels. A recent study found that even high-dose melatonin, ranging from 40 to 200 milligrams per day, was well tolerated in older adults over the long term. That is a dramatically better safety profile than prescription sleep medications like benzodiazepines or Z-drugs, which carry risks of falls, cognitive impairment, and dependence, all especially dangerous for older adults and people with dementia. However, prolonged melatonin use can lead to tachyphylaxis, meaning the body’s response to it diminishes over time. This can produce morning grogginess, headaches, and vivid dreams. If someone in your care has been taking melatonin nightly for months and says it stopped working, tachyphylaxis is a likely explanation.
Magnesium’s Quiet Case for Sleep in Older Adults
Among the natural sleep aids, magnesium has a particularly relevant story for anyone involved in dementia care or aging. An eight-week trial of 46 elderly subjects taking 500 milligrams of magnesium daily found statistically significant increases in sleep time, sleep efficiency, serum melatonin levels, and serum renin. The P values were strong across the board: 0.002 for sleep time, 0.03 for sleep efficiency, and 0.007 for serum melatonin. that last finding is especially interesting because it suggests magnesium may partly work by boosting the body’s own melatonin production rather than replacing it from outside. The form of magnesium matters more than most people realize.
A randomized controlled trial of 80 adults aged 35 to 55 tested magnesium L-threonate at one gram per day for 21 days and found improved sleep quality, particularly in deep and REM sleep stages, along with better mood, energy, and daytime alertness. Magnesium L-threonate has superior brain bioavailability compared to other forms like magnesium oxide or citrate, which makes it theoretically more relevant for neurological applications. For caregivers considering magnesium for an older family member, this distinction between forms is worth discussing with a physician. The overall evidence quality for magnesium and sleep has been described as substandard for making firm clinical recommendations, and much of the benefit may be concentrated in people who were magnesium-deficient to begin with. Given that deficiency is common in older adults, though, that caveat may actually strengthen the case for this population.
Glycine for Feeling Rested on Too Little Sleep
Glycine occupies an unusual niche among sleep supplements. Rather than promising more sleep, the evidence suggests it improves how rested people feel after sleep, a distinction that matters enormously for caregivers who simply cannot get a full night. The consistent dosage across trials is three grams taken 30 to 60 minutes before bedtime. In a polysomnographic study, that dose reduced sleep onset latency, improved sleep efficiency, and promoted faster entry into deeper sleep stages. The most compelling study for caregivers may be the sleep restriction trial by Bannai and colleagues, published in 2012.
After participants were limited to only five hours of sleep, those who had taken glycine showed significantly improved next-day alertness, reduced fatigue, and better working memory compared to those on placebo. The proposed mechanism is that glycine lowers core body temperature, which is a physiological prerequisite for sleep initiation, and modulates neurotransmitter activity in sleep-promoting brain regions. The tradeoff is straightforward: the evidence base is tiny. Only three small human studies exist, and all carry a high risk of bias due to their sample sizes. Glycine is inexpensive and has no reported safety concerns at these doses, but anyone expecting pharmaceutical-grade certainty will not find it here.
Why Valerian Root’s Long History Has Not Translated to Clear Evidence
Valerian root is one of the most widely used herbal sleep remedies in history, and yet the clinical picture remains stubbornly unclear. The largest systematic review, conducted by Shinjyo and colleagues in 2020, examined 60 studies with a combined 6,894 participants. A meta-analysis of ten of those studies found modest improvements in subjective sleep quality. An earlier meta-analysis by Bent and colleagues in 2006, covering 16 randomized controlled trials with 1,093 patients, found that people taking valerian were 1.8 times more likely to report improved sleep compared to placebo. But publication bias was flagged as a concern, and a conflicting review by Taibi in 2007 concluded the evidence did not support clinical efficacy.
The core problem is consistency. Valerian’s chemical composition varies dramatically depending on the plant species used, the extraction method, and even growing conditions. This makes cross-study comparison genuinely difficult. Two bottles labeled “valerian root” on a store shelf may contain meaningfully different compounds. On the safety side, no severe adverse events have been reported across studies involving participants aged 7 to 80, which at least means the risk of trying it is low. But for someone caring for a person with dementia, where drug interactions and cognitive side effects are constant concerns, the lack of standardization is a legitimate reason for caution.
Chamomile, CBD, and the Supplements That Fall Short
Chamomile showed significant improvements in sleep quality and fatigue scores compared to placebo after four weeks of use in a trial of older adults. It is mild, widely available, and has virtually no safety concerns, which makes it reasonable as a bedtime ritual even if the evidence is not as deep as that for melatonin or magnesium. CBD and cannabis, by contrast, have failed to deliver on their hype.
A 2025 systematic review found that cannabis use does not consistently improve objective sleep measures, including total sleep time, sleep latency, and sleep architecture. Given the cognitive risks that cannabis products pose for aging brains, this is an area where caution is warranted despite aggressive marketing claims. A broader 2025 systematic review of 71 natural products, including terpenoids, flavonoids, and polyphenols, concluded that additional rigorous clinical studies are needed to establish efficacy for virtually all of them. The supplement industry moves far faster than the research, and brain health claims are often built on animal studies or mechanistic speculation rather than human trials.
Where Sleep Science Is Headed for Aging and Brain Health
The connection between sleep disruption and neurodegenerative disease is now one of the most active areas of brain health research. Poor sleep accelerates amyloid-beta accumulation, worsens cognitive decline, and increases caregiver burden in dementia households. This means even modest improvements from supplements like magnesium or glycine could have outsized importance if they help someone get an additional cycle of deep sleep consistently.
Future research will likely focus on precision approaches, matching specific supplements to specific types of sleep disruption rather than treating insomnia as a monolith. The most promising direction for older adults may be combination strategies: addressing potential magnesium deficiency, using melatonin strategically rather than chronically to avoid tachyphylaxis, and incorporating behavioral interventions like light exposure timing and sleep restriction therapy. No supplement replaces sleep hygiene, but the clinical evidence, even where it is modest, suggests that certain natural aids have earned a place in the conversation.
Conclusion
The honest summary is that no natural sleep aid is a powerhouse. Melatonin has the most evidence but works best for specific circadian disruptions rather than general insomnia. Magnesium shows meaningful benefits for older adults, particularly those who may be deficient, with a 17-minute reduction in sleep onset latency in meta-analysis. Glycine has the most interesting subjective effects, improving how rested people feel even after short sleep, but the evidence base is still thin.
Valerian root remains unproven despite centuries of use. For caregivers and older adults navigating sleep problems alongside dementia concerns, the practical path forward involves talking with a physician about which of these options fits the specific sleep complaint, checking for magnesium deficiency as a baseline step, and being realistic about what supplements can and cannot do. Prescription sleep medications carry serious risks in aging populations, which gives even modestly effective natural alternatives a legitimate role. Start with the evidence, not the marketing.
Frequently Asked Questions
Is melatonin safe for people with dementia?
Melatonin has an excellent tolerability profile, and studies have shown even high doses of 40 to 200 milligrams per day are well tolerated in older adults long term. However, prolonged use can lead to reduced effectiveness and side effects like morning grogginess. Consult a physician familiar with the patient’s full medication list before starting.
How much magnesium should an older adult take for sleep?
The most-cited trial used 500 milligrams daily for eight weeks and found significant improvements in sleep time and efficiency. Magnesium L-threonate at one gram per day has also shown promise for sleep quality and deeper sleep stages due to its superior brain bioavailability. Dosing should be discussed with a doctor, especially for anyone with kidney concerns.
Does glycine interact with dementia medications?
Glycine at the studied dose of three grams before bedtime has not shown significant adverse effects in trials, but research is limited and none of the existing studies focused on dementia populations. Anyone on cholinesterase inhibitors or other neurological medications should check with their prescriber before adding glycine.
Why does valerian root work for some people but not others?
The chemical composition of valerian varies dramatically based on the plant species, growing conditions, and extraction method. Two products labeled as valerian root may contain substantially different active compounds. This inconsistency is the primary reason clinical trials have produced conflicting results.
Can I combine melatonin and magnesium for sleep?
Some clinicians do recommend this combination, since magnesium appears to support the body’s natural melatonin production. However, no large clinical trial has specifically studied the combination. Start one at a time to understand individual effects before combining, and always involve a healthcare provider.
Is CBD a good sleep aid for older adults?
A 2025 systematic review found that cannabis use does not consistently improve objective sleep measures including total sleep time, sleep latency, or sleep stages. Given the cognitive risks cannabis products may pose for aging brains, the current evidence does not support CBD as a reliable sleep aid for this population.
